VDP Clinical Prior Authorization Updates The Texas Vendor Drug Program will revise the following clinical prior authorization criteria on April 5: Cytokine and CAM Antagonists Criteria Oxbryta Criteria Phosphate Binder Criteria Other updates: Draft Specialty Drug List Available for Comment VDP System Maintenance Scheduled for This Weekend

---

You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website.

---

Stay Connected
					(en español)

Subscriber Services
Manage Preferences  |  Unsubscribe  |  Help

This email was sent to ooseims.archieves@blogger.com using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202